Longeveron Inc. Class A (LGVN) Live Share Price, Invest From India

Longeveron Inc. Class A Stock Performance

as on August 15, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.70
Day's Price Range
$0.75
$0.74
5.39%
Downside
1.37%
Upside
52 Week's Low
52 Week's High
$0.48
52-Week Price Range
$1.23
$0.74
35.80%
Downside
66.24%
Upside

Longeveron Inc. Class A share price movements today

Previous Close: $0.70
Open: $0.70
Volume: 769.9K
Day's Low - High: $0.70 - $0.75
52 Week Low - High: $0.48 - $1.23

Longeveron Inc. Class A Historical Returns

1 Month Return: + 12.1 %
3 Month Return: -0.71 %
1 Year Return: -7.63 %
3 Year Return: -97.71 %
5 Year Return: -98.21 %

Longeveron Inc. Class A Stock Fundamentals & Key Indicators

Check Longeveron Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.6M

EPS (TTM)

-0.68

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-21.6M

Revenue (TTM)

1.2M

Profit Margin

0.00%

Return On Equity TTM

-135.18%

Longeveron Inc. Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Longeveron Inc. Class A with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Longeveron Inc. Class A	BUY	$23.6M	-98.21%	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$44.0B	690.3%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$133.3B	165.71%	30.87	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$82.2B	29%	19.72	27.87%	0.45999999999999996%

Stock Returns calculator for Longeveron Inc. Class A Stock including INR - Dollar returns

The Longeveron Inc. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Longeveron Inc. Class A investment value today

Current value as on today

₹1,06,408

Returns

₹6,408

(+6.41%)

Returns from Longeveron Inc. Class A Stock

-₹2,645 (-2.64%)

Dollar Impact

₹9,053 (+9.05%)

Analyst Recommendation on Longeveron Inc. Class A Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Longeveron Inc. Class A. Average target price of $7.15

Longeveron Inc. Class A Share Price Target

Get share price movements and forecasts by analysts on Longeveron Inc. Class A.

What analysts predicted

89.65%UPSIDE

Target Price

$7.15

Current Price

$0.7399

Analyzed by

8 Analysts

Target

$7.15

Longeveron Inc. Class A target price $7.15, a slight upside of 89.65% compared to current price of $0.7399. According to 8 analysts rating.

Indian Investors' Interest in Longeveron Inc. Class A Stock

Search interest for Longeveron Inc. Class A Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 18, 2026 to August 17, 2026

Change:24% versus previous 30 day period

Longeveron Inc. Class A Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-4	-3	-4	-4	-5	-5	-7	-5	-4	-6
EBITDA	-3	-3	-4	-3	-4	-4	-6	-5	-4	-6
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-4	-3	-4	-4	-5	-5	-7	-5	-4	-6
Income Tax Expense	0	-	-	-	-	-	-	-	-	-
Net Income	-4	-3	-4	-4	-5	-5	-7	-5	-4	-6
Net Profit Margin	-740.51%	-729.27%	-571.67%	-676.78%	-1315.22%	-1591.14%	-5270.80%	-1491.51%	-1189.95%	-2116.03%

Longeveron Inc. Class A Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	2	5	5	1	1	0	2	1
Gross Profit	0	1	1	0	0	0	1	0
Operating Income	-6	-3	-3	-17	-18	-21	-16	-23
EBITDA	-5	-2	-2	-16	-17	-20	-15	-21
Interest Expense	-	0	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	1
Income Before Tax	-6	-3	-3	-17	-18	-21	-15	-22
Income Tax Expense	0	0	0	0	0	0	-24	-
Net Income	-6	-3	-3	-17	-18	-21	-15	-22
Net Profit Margin	-296.84%	-66.09%	-66.10%	-1305.13%	-1541.33%	-3020.17%	-667.77%	-1893.58%

Longeveron Inc. Class A Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-3	-4	-4	-5	-5	-7	-5	-4	-6
Operating Cash Flow	-4	-2	-3	-4	-3	-5	-5	-4	-5
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	15	13	0	0	0	4	0	15	0
Change in Cash	10	10	-3	-4	-3	-1	-4	11	-5

Longeveron Inc. Class A Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-3	-17	-18	-21	-15	-22
Operating Cash Flow	-2	-2	-9	-13	-19	-13	-18
Investing Cash Flow	0	0	-10	0	8	0	0
Financing Cash Flow	0	1	45	0	5	28	4
Change in Cash	-2	-1	24	-15	-5	14	-14

Global Institutional Holdings in Longeveron Inc. Class A

Funds	Holdings
ADAR1 Capital Management LLC	0.63%
Citadel Advisors Llc	0.07%
Capital Investment Advisory Services, LLC	0.08%
Commonwealth Equity Services, LLC	0.08%
Commonwealth Equity Services Inc	0.08%

See all

Insights on Longeveron Inc. Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 460.9% return, outperforming this stock by 463.5%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 581.3% return, outperforming this stock by 678.7%
NEGATIVE IMPACT
Price Dip
In the last 3 years, LGVN stock has moved down by -97.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -4.73M → -6.07M (in $), with an average decrease of 28.2% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 398.0K → 287.0K (in $), with an average decrease of 27.9% per quarter

About Longeveron Inc. Class A

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Organisation	Longeveron Inc. Class A
Headquarters	Life Science & Technology Park, Miami, FL, United States, 33136
Industry	Biotechnology
CEO	Mr. Stephen H. Willard Esq.
E-voting on shares	Click here to vote

Key Management of Longeveron Inc. Class A

Name	Title
Mr. Brian G Rash Ph.D.	Vice President of Research & Discovery
Dr. Joshua Michael Hare FACC, M.D.	Co-Founder, Chief Science Officer & Executive Chairman
Mr. Paul T. Lehr J.D.	General Counsel & Secretary
Mr. Stephen H. Willard Esq.	CEO & Director
Ms. Marie Washburn	Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Devin Blass	CTO and Senior VP of Chemistry, Manufacturing & Controls
Dr. Nataliya Agafonova M.D.	Chief Medical Officer
Ms. Lisa McClain-Moss	Vice President of Manufacturing

FAQs

What is Longeveron Inc. Class A share price today?

Longeveron Inc. Class A share price today is $0.74 as on August 15, 2026 at 8:45 am IST at the close of the market. Longeveron Inc. Class A share today touched a day high of $0.75 and a low of $0.70.

What is the 52 week high and 52 week low for Longeveron Inc. Class A share?

Longeveron Inc. Class A share touched a 52 week high of $1.23 on April 7, 2026 and a 52 week low of $0.48 on March 6, 2026. Longeveron Inc. Class A stock price today i.e. August 15, 2026 at 8:45 am IST is closed at $0.74,which is 39.85% down from its 52 week high and 55.77% up from its 52 week low.

What is Longeveron Inc. Class A's market capitalisation today?

Longeveron Inc. Class A market capitalisation is $0.00T as on August 15, 2026 at 8:45 am IST.

How to invest in Longeveron Inc. Class A Stock (LGVN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Longeveron Inc. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Longeveron Inc. Class A Shares that will get you 2.0273 shares as per Longeveron Inc. Class A share price of $0.74 per share as on August 15, 2026 at 8:45 am IST.

What is the minimum amount required to buy Longeveron Inc. Class A Stock (LGVN) from India?

Indian investors can start investing in Longeveron Inc. Class A (LGVN) shares with as little as ₹95.43 or $1 (as of August 17, 2026 at 1:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Longeveron Inc. Class A stock (as per the Rupee-Dollar exchange rate as on August 17, 2026 at 1:41 am IST). Based on Longeveron Inc. Class A share’s latest price of $0.74 as on August 15, 2026 at 8:45 am IST, you will get 13.5153 shares of Longeveron Inc. Class A. Learn more about fractional shares .

What are the returns that Longeveron Inc. Class A has given to Indian investors in the last 5 years?

Longeveron Inc. Class A stock has given -98.21% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?